for the Period Ended 31 March 2025
| Directors report | |
| Balance sheet | |
| Additional notes | |
| Balance sheet notes | |
| Community Interest Report |
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 31 March 2025
Principal activities of the company
Additional information
The company is a private company limited by guarantee and consequently does not have share capital. Each of the members is liable to contribute an amount not exceeding £1 towards the assets of the company in the event of liquidation.
Directors
The directors shown below have held office during the whole of the period from
1 April 2024
to
31 March 2025
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Director
As at
| Notes | 2025 | 2024 | |
|---|---|---|---|
|
|
£ |
£ |
|
| Fixed assets | |||
| Tangible assets: | 3 |
|
|
| Total fixed assets: |
|
|
|
| Current assets | |||
| Debtors: | 4 |
|
|
| Cash at bank and in hand: |
|
|
|
| Total current assets: |
|
|
|
| Creditors: amounts falling due within one year: | 5 |
(
|
(
|
| Net current assets (liabilities): |
|
|
|
| Total assets less current liabilities: |
|
|
|
| Total net assets (liabilities): |
|
|
|
| Members' funds | |||
| Profit and loss account: |
|
|
|
| Total members' funds: |
|
|
The notes form part of these financial statements
The directors have chosen not to file a copy of the company's profit and loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 March 2025
Basis of measurement and preparation
Turnover policy
Tangible fixed assets depreciation policy
Other accounting policies
for the Period Ended 31 March 2025
| 2025 | 2024 | |
|---|---|---|
| Average number of employees during the period |
|
|
for the Period Ended 31 March 2025
| Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total | |
|---|---|---|---|---|---|---|
| Cost | £ | £ | £ | £ | £ | £ |
| At 1 April 2024 |
|
|
||||
| Additions | ||||||
| Disposals | ||||||
| Revaluations | ||||||
| Transfers | ||||||
| At 31 March 2025 |
|
|
||||
| Depreciation | ||||||
| At 1 April 2024 |
|
|
||||
| Charge for year |
|
|
||||
| On disposals | ||||||
| Other adjustments | ||||||
| At 31 March 2025 |
|
|
||||
| Net book value | ||||||
| At 31 March 2025 |
|
|
||||
| At 31 March 2024 |
|
|
for the Period Ended 31 March 2025
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| Other debtors |
|
|
| Total |
|
|
for the Period Ended 31 March 2025
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| Other creditors |
|
|
| Total |
|
|
The Federation of Family Practices Lisburn C.I.C. has now completed their tenth period of account. They have obtained area wide coverage of practices within the Lisburn Area and obtained contributions from same. They have received funding from SPPG. Support of the practices enable the Federation to have a united voice in pushing forward schemes and funding which will improve training and education of our staff and ultimately will be for the benefit of our patients in the community. SPPG funding has been received for delivery of pharmacy services in general practice. The project fundamentally benefits patient care in the community.
The stakeholders are the members and their associated general practice surgeries. They hold regular board meetings where the members are informed of all activities and will be consulted on other matters before any major decision has been made.
The accounts detail directors’ remuneration in the year of £19,848. There were no other transactions or arrangements in connection with the remuneration of directors, or compensation for director’s loss of office, which require to be disclosed.
No transfer of assets other than for full consideration
This report was approved by the board of directors on
4 December 2025
And signed on behalf of the board by:
Name: Dr R Ryan
Status: Director